Combating COVID-19 with mesenchymal stem cell therapy

por Rajarshi, Keshav, Chatterjee, Aroni, Ray, Shashikant
Publicado 2020

BCG vaccination strategy implemented to reduce the impact of COVID-19: Hype or Hope?

por Rajarshi, Keshav, Chatterjee, Aroni, Ray, Shashikant
Publicado 2020

Convalescent plasma therapy: a promising coronavirus disease 2019 treatment strategy

por Piyush, Ravikant, Rajarshi, Keshav, Khan, Rajni, Ray, Shashikant
Publicado 2020

Nucleic acid-based therapy for coronavirus disease 2019

por Piyush, Ravikant, Rajarshi, Keshav, Chatterjee, Aroni, Khan, Rajni, Ray, Shashikant
Publicado 2020

Combining SARS-CoV-2 Proofreading Exonuclease and RNA-Dependent RNA Polymerase Inhibitors as a Strategy to Combat COVID-19: A High-Throughput in silico Screening

por Khater, Shradha, Kumar, Pawan, Dasgupta, Nandini, Das, Gautam, Ray, Shashikant, Prakash, Amresh
Publicado 2021

Essential functional molecules associated with SARS-CoV-2 infection: Potential therapeutic targets for COVID-19

por Rajarshi, Keshav, Khan, Rajni, Singh, Mrityunjay K., Ranjan, Tushar, Ray, Sandipan, Ray, Shashikant
Publicado 2021

Arylcoumarin perturbs SARS-CoV-2 pathogenesis by targeting the S-protein/ACE2 interaction

por Singh, Ruhar, Kumar, Abhijeet, Rane, Jitendra Subhash, Khan, Rajni, Tripathi, Garima, Ajay, Amrendra K., Prakash, Amresh, Ray, Shashikant
Publicado 2022